Critical Comparison: ALT5 Sigma (NASDAQ:ALTS) and Imation (OTCMKTS:GLAE)

Imation (OTCMKTS:GLAE) and ALT5 Sigma (NASDAQ:ALTS) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership.

Risk & Volatility

Imation has a beta of 7.44, indicating that its share price is 644% more volatile than the S&P 500. Comparatively, ALT5 Sigma has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500.

Valuation & Earnings

This table compares Imation and ALT5 Sigma”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Imation	N/A	N/A	N/A	N/A	N/A
ALT5 Sigma	$12.53 million	17.85	-$6.24 million	N/A	N/A

Imation has higher earnings, but lower revenue than ALT5 Sigma.

Insider and Institutional Ownership

6.3% of ALT5 Sigma shares are owned by institutional investors. 9.2% of Imation shares are owned by insiders. Comparatively, 0.2% of ALT5 Sigma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for Imation and ALT5 Sigma, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Imation	0	0	0	0	0.00
ALT5 Sigma	1	0	0	0	1.00

Profitability

This table compares Imation and ALT5 Sigma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Imation	N/A	N/A	N/A
ALT5 Sigma	133.06%	8.60%	7.10%

Summary

ALT5 Sigma beats Imation on 6 of the 8 factors compared between the two stocks.

About Imation

GlassBridge Enterprises, Inc., through its subsidiaries, owns and operates an asset management business in the United States. It offers investment advisory services to third party investors through managed funds separate managed accounts. The company was formerly known as Imation Corp. and changed its name to GlassBridge Enterprises, Inc. in February 2017. GlassBridge Enterprises, Inc. was incorporated in 1996 and is headquartered in New York, New York.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.